Biological Markers
Research News and Information

Saturday, November 21, 2009

The influence of chronic periodontitis on serum TNF-alpha, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients.

14 Dec 2009 OBJECTIVE: The aim of the study is to analyze whether chronic periodontitis (CP) influences serum tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and high-sensitivity C-reactive protein (hs-CRP) concentrations in renal transplant recipients ... Read more...

Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.

13 Dec 2009 BACKGROUND: Progressive neurodegeneration may result in potentially severe cognitive and motor dysfunctions as a complication of Langerhans cell histiocytosis (LCH), a suggested IL-17A-associated inflammatory condition. To detect this complication ... Read more...

Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.

13 Dec 2009 BACKGROUND: The currently used National Cancer Institute (NCI) adverse events criteria for mucosal barrier injury (MBI) are insufficient for use in children. We searched for objective, easily measurable indicators for MBI in children with cancer. ... Read more...

Latest indexed articles for 'Biological Markers'

These are the very latest articles for this heading:

• The influence of chronic periodontitis on serum TNF-alpha, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients. 14 Dec 2009
• Biomarkers for mucositis assessment. 13 Dec 2009
• Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis. 13 Dec 2009
• Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients. 13 Dec 2009
• Prognostic value of proangiogenic cytokines in children with lymphomas. 13 Dec 2009
• Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. 6 Dec 2009
• Biomarkers of lung-related diseases: current knowledge by proteomic approaches. 29 Nov 2009
• Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin. 29 Nov 2009
• Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. 29 Nov 2009
• The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma. 18 Nov 2009
• Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers. 13 Nov 2009
• Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study. Nov 2009
• Benign fibroblastic polyps of the colon. 30 Oct 2009
• Relationship between intracranial hemodynamics and microdialysis markers of energy metabolism and glutamate-glutamine turnover in patients with subarachnoid hemorrhage. Clinical article. 30 Oct 2009
• Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus. 30 Oct 2009
• Lithium response across generations. 30 Oct 2009
• Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. 30 Oct 2009
• Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. 30 Oct 2009
• Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer. 30 Oct 2009
• The cellular and molecular immune response of the weanling piglet to staphylococcal enterotoxin B. 30 Oct 2009

See a longer list of these articles.

Technical information about 'Biological Markers'

Definition: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.

Registry Number: 0

Descriptor UI: D015415

Alternative terms: Biological Markers; Markers, Biological; Biomarkers; Marker, Biological; Biological Marker; Biologic Marker; Marker, Biologic; Biologic Markers; Markers, Biologic; Viral Markers; Viral Marker; Marker, Viral; Markers, Viral; Biochemical Marker; Marker, Biochemical; Markers, Biochemical; Biochemical Markers; Surrogate Endpoints; Endpoints, Surrogate; Surrogate End Points; End Points, Surrogate; Surrogate Endpoint; Endpoint, Surrogate; Surrogate End Point; End Point, Surrogate; Markers, Immunologic; Marker, Immunologic; Immunologic Marker; Immunologic Markers; Immune Marker; Marker, Immune; Immune Markers; Markers, Immune; Markers, Laboratory; Laboratory Markers; Marker, Laboratory; Laboratory Marker; Serum Markers; Markers, Serum; Serum Marker; Marker, Serum; Surrogate Markers; Markers, Surrogate; Surrogate Marker; Marker, Surrogate; Markers, Clinical; Clinical Markers; Marker, Clinical; Clinical Marker;

Related Mesh Headings: Molecular Probes;

Allowable Qualifiers: analysis; blood; cerebrospinal fluid; chemistry; metabolism; urine;

Tree Number: D23.101;

History Note: 89

Technical Notes: IM general only; coordinate NIM with specific substance (IM); note that many specific markers are available; DF: BIOL MARKERS